Search | TVST | ARVO Journals

Showing 1 – 20 of 126

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Clinical Trials July 2024

Utility of a Model to Predict Endothelial Cell Density of Donor Corneas to Determine Suitability for Transplantation

PDF

Julia B. Bu; Stephanie D. Grabitz; Franziska Schön; Melissa Apel; Tobias Pusch; Adrian Gericke; Alicia Poplawski; Norbert Pfeiffer; Joanna Wasielica-Poslednik
TAGS: cornea, donors, endothelial cells, transplantation
Trans. Vis. Sci. Tech.. 2024; 13(7):21. https://doi.org/10.1167/tvst.13.7.21

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2024

Blue light-induced mitochondrial oxidative damage underlay retinal pigment epithelial cell apoptosis

Mohamed Abdouh; Yunxi Chen; Alicia Alejandra Goyeneche; Julia Burnier; Guilherme Sottomaior; Stephanie Pessoa Regueira; Miguel N Burnier

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4978.

ARVO Annual Meeting Abstract June 2024

Oral alpha-cyclodextrin targets the gut-retinal axis and corrects diabetic retinopathy (DR) in a mouse model of type 2 diabetes (T2D).

Yvonne Adu-Agyeiwaah; Ram Prasad; Sergio Li Calzi; Bright Asare Bediako; Jason Floyd; Mariana D Dupont; Tim Florian Dorweiler; Cristiano Vieira; Irina A Pikuleva; Julia Busik; Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):836.

ARVO Annual Meeting Abstract June 2024

The calvarium bone marrow responds to acute retinal injury and is resilient to chronic diabetes compared to long bone marrow.

Sergio Li Calzi; Bright Asare-Bediako; Ram Prasad; Yvonne Adu-Agyeiwaah; Robert F Rosencrans; Jason Floyd; Denise Stanford; Anna Lin; Todd A Lydic; Michael Boulton; Julia Busik; Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):325.

ARVO Annual Meeting Abstract June 2024

Uveal melanoma and peripheral blood mononuclear cells co-culture induced an immunosuppressive phenotype

Alicia Alejandra Goyeneche; Cristina Fonseca; Mohamed Abdouh; Julia Burnier; Ana Eller; Carolina Santos; Miguel N Burnier

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2262.

ARVO Annual Meeting Abstract June 2024

Systemic anti-ceramide immunotherapy corrects diabetic retinopathy by restoring hematopoietic stem cell function

Tim Florian Dorweiler; Arjun Singh; Sandra O'Reilly; Gary Blanchard; Maria B Grant; Richard Kolesnick; Julia V Busik

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3836.

ARVO Annual Meeting Abstract June 2023

Utility of a model to predict endothelial cell density of donor corneas to determine suitability for transplantation: a decision curve analysis.

Stephanie Desiree Grabitz; Julia Bing Bu; Franziska Schön; Melissa Apel; Tobias Pusch; Adrian Gericke; Alicia Poplawski; Norbert Pfeiffer; Joanna Wasielica-Poslednik

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):651.

ARVO Annual Meeting Abstract June 2023

Inhibition of ceramide rich platforms by anti-ceramide immunotherapy prevents retinal endothelial cell damage and the development of diabetic retinopathy.

Tim F. Dorweiler; Arjun Singh; Richard N Kolesnick; Julia V. Busik

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):941.

ARVO Annual Meeting Abstract June 2023

LP-ACE2 attenuates diabetic visual impairment by improving gut barrier integrity and intestinal lymphatics in type 1 diabetes

Ram Prasad; Jason Floyd; Yvonne Adu-Agyeiwaah; Bright Asare-Bediako; Sergio Li Calzi; Dibyendu Chakraborty; Angela Harbour; Aayush Rohella; Irina A Pikuleva; Julia V. Busik; Qiuhong Li; Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):938.

ARVO Annual Meeting Abstract June 2023

Characterization of uveal melanoma-derived EV protein cargo for the determination of new therapeutic targets

Mohamed Abdouh; Thupten Tsering; Carmen Luz-Pessuti; Miguel N. Burnier; Emma Youhnovska; Julia Valdemarin Burnier

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):879.

ARVO Annual Meeting Abstract June 2023

Extracellular Vesicles in Diabetic Retinopathy

Julia V. Busik

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1944.

ARVO Annual Meeting Abstract June 2023

Oral alpha-cyclodextrin reverses cholesterol-crystal-induced retinal pathology in a rodent model of type 2 diabetes (T2D).

Yvonne Adu-Agyeiwaah; Bright Asare-Bediako; Jason Floyd; Mariana D DuPont; Cristiano Vieira; Ram Prasad; Sergio Li Calzi; Irina A Pikuleva; Julia V. Busik; Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1834.

ARVO Annual Meeting Abstract June 2023

Calvarium bone marrow is the source of bone marrow-derived cells that migrate into the injured retina

Sergio Li Calzi; Bright Asare-Bediako; Yvonne Adu-Agyeiwaah; Ram Prasad; Julia V. Busik; Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3866.

ARVO Annual Meeting Abstract June 2023

Delineating three-dimensional behavior of uveal melanoma cells under anchorage independent or dependent methods

Alicia Alejandra Goyeneche; Jade Marie Lasiste; Prisca Bustamante; Mohamed Abdouh; Julia Valdemarin Burnier; Anne Xuan-Lan Nguyen; Miguel N. Burnier

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):881.

Retina April 2023

Intravitreal Administration of AAV2-SIRT1 Reverses Diabetic Retinopathy in a Mouse Model of Type 2 Diabetes

PDF

Yvonne Adu-Agyeiwaah; Cristiano P. Vieira; Bright Asare-Bediako; Sergio Li Calzi; Mariana DuPont; Jason Floyd; Sanford Boye; Vince Chiodo; Julia V. Busik; Maria B. Grant
TAGS: diabetes mellitus, diabetes mellitus, type 2, diabetic retinopathy, intravitreal injections, mice, retina, blood capillaries, inflammation, hypoxia
Trans. Vis. Sci. Tech.. 2023; 12(4):20. https://doi.org/10.1167/tvst.12.4.20

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2022

Filtering blue light mitigates the deleterious effects induced by the oxidative stress in primary human retinal pigment epithelial cells

Mohamed Abdouh; Melissa Lu; Yunxi Chen; Alicia Alejandra Goyeneche; Julia Valdemarin Burnier; Miguel N Burnier

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):466 – A0003.

ARVO Annual Meeting Abstract June 2022

Anti-ceramide immunotherapy for diabetic retinopathy

Tim Florian Dorweiler; Peter Nolan; Richard N. Kolesnick; Julia V Busik

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):459.

ARVO Annual Meeting Abstract June 2022

Correction of diabetic retinopathy by mitochondrial transfer

Denis A Proshlyakov; Sandra S Hammer; Sergio Li Calzi; Tim Florian Dorweiler; Cristiano P. Vieira; Kiera Fisher; Shari Atilano; M.Cristina Kenney; Julia V Busik; Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):791 – F0350.

ARVO Annual Meeting Abstract June 2022

Intermittent fasting prevents cholesterol accumulation, cholesterol crystal formation and the development of diabetic retinopathy.

Sandra S Hammer; Maria B Grant; Julia V Busik

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):782 – F0341.

ARVO Annual Meeting Abstract June 2022

Effect of artificial sunlight spectrum on keratinocytes and fibroblasts and the consequences of ultraviolet radiation blockage

Alicia Alejandra Goyeneche; Emma Youhnovska; Mohamed Abdouh; Julia Valdemarin Burnier; Miguel N Burnier

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2365 – A0049.

1 2 3 4 5

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Utility of a Model to Predict Endothelial Cell Density of Donor Corneas to Determine Suitability for Transplantation

Blue light-induced mitochondrial oxidative damage underlay retinal pigment epithelial cell apoptosis

Oral alpha-cyclodextrin targets the gut-retinal axis and corrects diabetic retinopathy (DR) in a mouse model of type 2 diabetes (T2D).

The calvarium bone marrow responds to acute retinal injury and is resilient to chronic diabetes compared to long bone marrow.

Uveal melanoma and peripheral blood mononuclear cells co-culture induced an immunosuppressive phenotype

Systemic anti-ceramide immunotherapy corrects diabetic retinopathy by restoring hematopoietic stem cell function

Utility of a model to predict endothelial cell density of donor corneas to determine suitability for transplantation: a decision curve analysis.

Inhibition of ceramide rich platforms by anti-ceramide immunotherapy prevents retinal endothelial cell damage and the development of diabetic retinopathy.

LP-ACE2 attenuates diabetic visual impairment by improving gut barrier integrity and intestinal lymphatics in type 1 diabetes

Characterization of uveal melanoma-derived EV protein cargo for the determination of new therapeutic targets

Extracellular Vesicles in Diabetic Retinopathy

Oral alpha-cyclodextrin reverses cholesterol-crystal-induced retinal pathology in a rodent model of type 2 diabetes (T2D).

Calvarium bone marrow is the source of bone marrow-derived cells that migrate into the injured retina

Delineating three-dimensional behavior of uveal melanoma cells under anchorage independent or dependent methods

Intravitreal Administration of AAV2-SIRT1 Reverses Diabetic Retinopathy in a Mouse Model of Type 2 Diabetes

Filtering blue light mitigates the deleterious effects induced by the oxidative stress in primary human retinal pigment epithelial cells

Anti-ceramide immunotherapy for diabetic retinopathy

Correction of diabetic retinopathy by mitochondrial transfer

Intermittent fasting prevents cholesterol accumulation, cholesterol crystal formation and the development of diabetic retinopathy.

Effect of artificial sunlight spectrum on keratinocytes and fibroblasts and the consequences of ultraviolet radiation blockage

To View More...

You must be signed into an individual account to use this feature.